Carcinoid Syndrome: Recognizing Symptoms and Flare Triggers

Carcinoid syndrome is an uncommon complication of some well-differentiated neuroendocrine tumors (NETs). The tumor may release serotonin and other mediators into the bloodstream, producing symptoms that can involve the gut, skin, airways, circulation, and heart. [5][10]

The presentation is not always classic. Persistent watery diarrhea, weight loss, swelling, or unexplained right-sided heart-valve disease may be prominent even when flushing or bronchospasm is absent. [1]

1. What Is Carcinoid Syndrome?

Carcinoid syndrome describes signs and symptoms caused by a carcinoid tumor or another well-differentiated NET that secretes serotonin and other peptides into the bloodstream. These tumors commonly arise in the gastrointestinal tract, although pulmonary carcinoids are also well-differentiated neuroendocrine tumors. [5][9]

Having a carcinoid tumor does not automatically mean a person has carcinoid syndrome. One review states that about 10% of people with carcinoid tumors experience the syndrome, while ENETS guidance reports symptoms of carcinoid syndrome in around 30% of patients with small-intestinal NETs. These figures describe different tumor populations. [5][7]

2. How Does Carcinoid Syndrome Develop?

Well-differentiated NETs can release serotonin and other biologically active mediators. These substances can affect intestinal activity, blood vessels, airways, and the cardiovascular system, contributing to diarrhea, flushing, hypotension, tachycardia, and bronchospasm. [3][5][10]

For gastrointestinal NETs, carcinoid syndrome is often seen when metastatic disease involves the liver, allowing tumor products to reach the systemic circulation. Prolonged exposure to circulating mediators can produce plaque-like fibrous changes on heart valves, particularly the tricuspid and pulmonary valves. The resulting valve dysfunction can lead to edema, ascites, and right-sided heart failure. [1][10]

Evidence supplied for this article does not establish universal everyday dietary or activity triggers for symptom episodes. However, procedures and surgery require careful planning because uncontrolled mediator release can lead to carcinoid crisis with hemodynamic instability, bronchospasm, and arrhythmias. [3]

3. Causes of Carcinoid Syndrome

Carcinoid syndrome is caused by a hormone-producing carcinoid tumor or another well-differentiated NET. The syndrome reflects the tumor’s secretion of serotonin and other peptides or vasoactive mediators, not a dietary intolerance or routine gastrointestinal infection. Gastrointestinal tumors, especially small-intestinal NETs, are an important setting for the syndrome; liver metastases can increase systemic exposure to tumor products. Pulmonary carcinoid tumors are another type of well-differentiated NET. [5][7][9]

4. Risk Factors

5. Signs & Symptoms

Symptoms vary in type and severity. Some people have episodic vasomotor or breathing symptoms, while others have persistent diarrhea or signs of carcinoid heart disease. Not having flushing does not rule out the syndrome. [1][3][5]

• Watery diarrhea: Persistent or recurrent watery stools are a recognized presentation and can contribute to volume depletion, weight loss, and electrolyte disturbance. [1][10]
• Facial flushing: Flushing is a common finding and reflects the vascular effects of tumor mediators. [5]
• Tachycardia: A rapid heartbeat may occur as part of the syndrome’s vasomotor presentation. [5]
• Shortness of breath: Breathlessness is a reported feature and may also occur with cardiac involvement. [5][10]
• Bronchospasm or wheezing: Some people develop airway tightening as part of episodic carcinoid symptoms or carcinoid crisis. [3][10]
• Hypotension: Low blood pressure can occur with vasomotor symptoms and can be severe during carcinoid crisis. [3][10]
• Unintentional weight loss: Weight loss may accompany chronic diarrhea and advanced NET disease. [1]
• Leg swelling or abdominal fluid: Edema and ascites can result from right-sided heart failure caused by carcinoid-related valve dysfunction. [10]

6. How Is Carcinoid Syndrome Diagnosed?

Evaluation starts with the symptom history, medication history, and physical examination, followed by biochemical assessment and tumor staging. Clinicians assess for diarrhea, flushing, breathing symptoms, weight change, dehydration, edema, and features suggesting right-sided heart involvement. When a NET is identified, pathology is required to confirm and classify the tumor. [1][5][7][9]

• Clinical history and examination: Recurrent diarrhea, flushing, tachycardia, respiratory symptoms, weight loss, edema, and signs of right-sided heart failure may raise concern. [1][3][5][10]
• Twenty-four-hour urinary 5-HIAA: This test measures a serotonin breakdown product. An elevated result supports serotonin excess in the appropriate clinical context. [1][5]
• Serum chromogranin A: This tumor-associated marker may be elevated in NETs and is interpreted with the clinical picture and imaging. [1][5][9]
• Cross-sectional imaging: CT can identify masses, mesenteric disease, liver lesions, and other evidence relevant to tumor staging. [1][9]
• Somatostatin-receptor imaging: Functional imaging is important for staging and treatment-related decisions in small-intestinal NETs and may help assess metastatic disease. [7][9]
• Echocardiography: An echocardiogram assesses valve structure and function when carcinoid heart disease is suspected. [1][10]
• Biopsy and pathology: Tissue examination confirms the underlying NET and determines tumor differentiation and grade. [1][9]

7. Differential Diagnosis

8. Treatment Options

Treatment depends on symptom burden, tumor site and extent, biochemical activity, heart involvement, and overall clinical circumstances. Management decisions should be made through an experienced multidisciplinary team; ENETS guidance recommends specialist expertise for small-intestinal NET care. [7][10]

10. When to Seek Emergency Medical Help